H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home


Monday, 27 September 2021
Prof Kelly Chibale discusses the importance of optimised dosing for African populations

Prof Kelly Chibale is passionate about improving the treatment outcomes of African patients. Read more about why and how his group is understanding drug metabolism in the African population.

Publication Date:
Fri, 22 Jan 2021 - 07:15
"No leader should be feared" Prof Kelly Chibale chats about leadership, laughter and more

Prof Kelly Chibale, founder and director of H3D, was recently interviewed by Chemistry World on his views on leadership, teamwork and his love for science. Read the full article here

Publication Date:
Mon, 02 Nov 2020 - 07:15
Prof Kelly Chibale discusses stemming Africa's brain drain

Prof Kelly Chibale published an article in the Medicine Maker on how African Pharma has a promising role in changing the afro-pessimistic sentiment, so that we may begin to attract and retain skilled African scientists.

Publication Date:
Sun, 25 Oct 2020 - 07:15
Why and how Africa can be at the forefrunt of clinical trial research- Prof Kelly Chibale

Prof Kelly Chibale published an article in the Daily Maverick on how the Oxford Vaccine Trial is an opportunity for African scientists to lead, earn respect & credibility, and show that Africans can be at the forefront of clinical trial research.

Publication Date:
Sun, 13 Sep 2020 - 07:45